ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $21,000 | -95.2% | 708 | -94.5% | 0.00% | -100.0% |
Q4 2018 | $433,000 | -15.8% | 12,889 | +5.8% | 0.01% | +33.3% |
Q3 2018 | $514,000 | +63.2% | 12,181 | +23.7% | 0.01% | +50.0% |
Q2 2018 | $315,000 | -53.6% | 9,849 | -27.8% | 0.01% | -62.5% |
Q1 2018 | $679,000 | – | 13,648 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |